Vaxcyte, Inc. - PCVX

SEC FilingsOur PCVX Tweets

About Gravity Analytica

Recent News

  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.05.2025 - Jefferies Global Healthcare Conference
  • 06.05.2025 - Jefferies Global Healthcare Conference
  • 05.13.2025 - BofA Securities 2025 Health Care Conference
  • 05.13.2025 - BofA Securities 2025 Health Care Conference
  • 05.07.2025 - Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
  • 05.07.2025 - Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
  • 05.01.2025 - Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
  • 05.01.2025 - Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

Recent Filings

  • 05.02.2025 - 3 Initial statement of beneficial ownership of securities
  • 05.02.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.01.2025 - 8-K Current report
  • 04.28.2025 - ARS Annual Report to Security Holders
  • 04.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 04.28.2025 - DEF 14A Other definitive proxy statements
  • 04.25.2025 - 3 Initial statement of beneficial ownership of securities
  • 04.18.2025 - PRE 14A Other preliminary proxy statements
  • 04.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 04.10.2025 - 4 Statement of changes in beneficial ownership of securities